A program supported by NIGMS and NICHD will give grants to studies that will use molecular or genomic approaches evaluating behavior in animal models.
The strategic partnerships will use multi-disciplinary research to study how multi-analyte signatures of tumors may be applied to cancer treatments.
Funded with $1.25 million in 2010, the grants will support studies of epigenetic factors that affect disease symptoms and complications.
NCI and NHLBI plan to give $12 million each for research into molecular, genetic, and other connections between the two diseases.
The CADET programs will support two-year projects for centers to develop diagnostics and therapeutics for lung diseases.
With up to $25 million, the MAPGen organ system centers will study underlying causes of heart, lung, blood, and sleep disorders.
The non-profit institute will use $6.7 million to establish an NCI Integrative Cancer Biology Program Center.
The Centralized Protein Sequence and Function Resource would house proteomics and related information for researchers.
The $20 million program will support development of tools for NIAID priorities including diagnostics, therapeutics, vaccines, and others.
The grants of up to $5.25 million this year will support partnerships focused on ethnic and racial disparities in cancer.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.